1. Home
  2. ZS vs IQV Comparison

ZS vs IQV Comparison

Compare ZS & IQV Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.

Logo Zscaler Inc.

ZS

Zscaler Inc.

HOLD

Current Price

$186.30

Market Cap

35.1B

Sector

Technology

ML Signal

HOLD

Logo IQVIA Holdings Inc.

IQV

IQVIA Holdings Inc.

HOLD

Current Price

$201.42

Market Cap

41.3B

Sector

Health Care

ML Signal

HOLD

Company Overview

Basic Information
Metric
ZS
IQV
Founded
2007
1982
Country
United States
United States
Employees
N/A
N/A
Industry
EDP Services
Biotechnology: Commercial Physical & Biological Resarch
Sector
Technology
Health Care
Exchange
Nasdaq
Nasdaq
Market Cap
35.1B
41.3B
IPO Year
2018
2013

Fundamental Metrics

Financial Performance
Metric
ZS
IQV
Price
$186.30
$201.42
Analyst Decision
Buy
Buy
Analyst Count
34
15
Target Price
$318.42
$242.60
AVG Volume (30 Days)
1.9M
1.4M
Earning Date
03-04-2026
02-05-2026
Dividend Yield
N/A
N/A
EPS Growth
N/A
N/A
EPS
N/A
7.30
Revenue
$2,833,272,000.00
$15,904,000,000.00
Revenue This Year
$27.01
$6.14
Revenue Next Year
$19.32
$5.44
P/E Ratio
N/A
$27.90
Revenue Growth
23.24
3.85
52 Week Low
$164.78
$134.65
52 Week High
$336.99
$247.05

Technical Indicators

Market Signals
Indicator
ZS
IQV
Relative Strength Index (RSI) 25.09 25.04
Support Level $197.47 $227.99
Resistance Level $229.00 $233.48
Average True Range (ATR) 7.50 8.23
MACD -1.22 -4.46
Stochastic Oscillator 15.99 10.68

Price Performance

Historical Comparison
ZS
IQV

About ZS Zscaler Inc.

Zscaler is a software-as-a-service, or SaaS, firm focusing on providing cloud-native cybersecurity solutions to primarily enterprise customers. Zscaler's offerings can be broadly partitioned into Zscaler Internet Access, which provides secure access to external applications, and Zscaler Private Access, which provides secure access to internal applications. The firm is headquartered in San Jose, California, and went public in 2018.

About IQV IQVIA Holdings Inc.

Iqvia is the result of the 2016 merger of Quintiles, a leading global contract research organization, and IMS Health, a leading healthcare data and analytics provider. The research and development segment focuses primarily on providing outsourced late-stage clinical trials for pharmaceutical, device, and diagnostic firms. The technology and analytics segment provides aggregated information and technology services to clients in the healthcare industry, including pharmaceutical companies, providers, payers, and policymakers, as well as data and analytics capabilities for clinical trials, including virtual trials. The company also has a small contract sales business.

Share on Social Networks: